Literature DB >> 11882026

Transgenic models of autoimmune disease.

R J Boyton1, D M Altmann.   

Abstract

Transgenic and knockout mouse models have been invaluable for the elucidation of basic mechanisms in autoimmunity and have contributed new experimental models of human autoimmune diseases. Transgenic models of self tolerance have helped to change our view of this state from a process mediated purely by thymic deletion to a more complex process encompassing deletion, peripheral anergy, down-regulation of receptors and modulation by regulatory cells. Experiments in which the genes for the candidate target antigens in autoimmune disease are over-expressed or under-expressed have helped to clarify the targets of attack. Several examples of T cell receptor transgenic mice have been described in which T cells carry the receptor derived from a human or mouse autoimmune T cell clone. Such mice allow the characterization of T cell specificities contributing to disease and of the additional factors and checkpoints influencing disease development. In addition, the expression of disease associated HLA alleles in 'humanised' transgenic lines allows the mapping of HLA-restricted T cell epitopes and investigation of the mechanisms underlying these genetic associations. These approaches are leading to the generation of new disease models, offering hope for the design and testing of novel immunotherapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11882026      PMCID: PMC1906292          DOI: 10.1046/j.1365-2249.2002.01771.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  60 in total

1.  T cell responses to a human cartilage autoantigen in the context of rheumatoid arthritis-associated and nonassociated HLA-DR4 alleles.

Authors:  A P Cope; S D Patel; F Hall; M Congia; H A Hubers; G F Verheijden; A M Boots; R Menon; M Trucco; A W Rijnders; G Sønderstrup
Journal:  Arthritis Rheum       Date:  1999-07

2.  Induction of autoimmune arthritis in HLA-DR4 (DRB1*0401) transgenic mice by immunization with human and bovine type II collagen.

Authors:  E F Rosloniec; D D Brand; L K Myers; Y Esaki; K B Whittington; D M Zaller; A Woods; J M Stuart; A H Kang
Journal:  J Immunol       Date:  1998-03-15       Impact factor: 5.422

3.  Control of autoimmune diabetes in NOD mice by GAD expression or suppression in beta cells.

Authors:  J W Yoon; C S Yoon; H W Lim; Q Q Huang; Y Kang; K H Pyun; K Hirasawa; R S Sherwin; H S Jun
Journal:  Science       Date:  1999-05-14       Impact factor: 47.728

4.  Major DQ8-restricted T-cell epitopes for human GAD65 mapped using human CD4, DQA1*0301, DQB1*0302 transgenic IA(null) NOD mice.

Authors:  J Liu; L E Purdy; S Rabinovitch; A M Jevnikar; J F Elliott
Journal:  Diabetes       Date:  1999-03       Impact factor: 9.461

5.  T cell epitopes of insulin defined in HLA-DR4 transgenic mice are derived from preproinsulin and proinsulin.

Authors:  M Congia; S Patel; A P Cope; S De Virgiliis; G Sønderstrup
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

6.  Induction of insulitis by glutamic acid decarboxylase peptide-specific and HLA-DQ8-restricted CD4(+) T cells from human DQ transgenic mice.

Authors:  L Wen; F S Wong; L Burkly; M Altieri; C Mamalaki; D Kioussis; R A Flavell; R S Sherwin
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

7.  Widespread expression of an autoantigen-GAD65 transgene does not tolerize non-obese diabetic mice and can exacerbate disease.

Authors:  L Geng; M Solimena; R A Flavell; R S Sherwin; A C Hayday
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

8.  Glutamic acid decarboxylase T lymphocyte responses associated with susceptibility or resistance to type I diabetes: analysis in disease discordant human twins, non-obese diabetic mice and HLA-DQ transgenic mice.

Authors:  R J Boyton; T Lohmann; M Londei; H Kalbacher; T Halder; A J Frater; D C Douek; D G Leslie; R A Flavell; D M Altmann
Journal:  Int Immunol       Date:  1998-12       Impact factor: 4.823

9.  Differential protection in two transgenic lines of NOD/Lt mice hyperexpressing the autoantigen GAD65 in pancreatic beta-cells.

Authors:  M Bridgett; M Cetkovic-Cvrlje; R O'Rourke; Y Shi; S Narayanswami; J Lambert; V Ramiya; S Baekkeskov; E H Leiter
Journal:  Diabetes       Date:  1998-12       Impact factor: 9.461

10.  Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis.

Authors:  D Olivares-Villagómez; Y Wang; J J Lafaille
Journal:  J Exp Med       Date:  1998-11-16       Impact factor: 14.307

View more
  5 in total

1.  Myelin-reactive type B T cells and T cells specific for low-affinity MHC-binding myelin peptides escape tolerance in HLA-DR transgenic mice.

Authors:  Kazuyuki Kawamura; Katherine A McLaughlin; Robert Weissert; Thomas G Forsthuber
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

Review 2.  The use of mouse models to better understand mechanisms of autoimmunity and tolerance.

Authors:  Fumi Miyagawa; Jan Gutermuth; Hong Zhang; Stephen I Katz
Journal:  J Autoimmun       Date:  2010-07-23       Impact factor: 7.094

3.  Identification of T-cell epitopes in Francisella tularensis using an ordered protein array of serological targets.

Authors:  Michael D Valentino; Zachary J Maben; Lucinda L Hensley; Matthew D Woolard; Thomas H Kawula; Jeffrey A Frelinger; John G Frelinger
Journal:  Immunology       Date:  2011-01-07       Impact factor: 7.397

Review 4.  T-cell-mediated autoimmunity: novel techniques to characterize autoreactive T-cell receptors.

Authors:  Klaus Dornmair; Norbert Goebels; Hans-Ulrich Weltzien; Hartmut Wekerle; Reinhard Hohlfeld
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

5.  Lymphocytes with aberrant expression of Fas or Fas ligand attenuate immune bone marrow failure in a mouse model.

Authors:  Stephanie O Omokaro; Marie J Desierto; Michael A Eckhaus; Felicia M Ellison; Jichun Chen; Neal S Young
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.